V

VaxInnate Corporation

25 employees

VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Diagnostics
Health Care

Date founded

2001

Funding rounds raised

Total raised

$40M

from 10 investors over 10 rounds

V

VaxInnate Corporation raised $6M on October 2, 2014

Investors: Saints Capital

V

VaxInnate Corporation raised $2.2M on April 4, 2013

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

V

VaxInnate Corporation raised $30M on June 14, 2009

Investors: New Leaf Venture Partners, Canaan, HealthCare Ventures LLC and Wellcome Trust

V

VaxInnate Corporation raised $40M on October 25, 2006

Investors: Canaan, HealthCare Ventures LLC and New Leaf Venture Partners

V

VaxInnate Corporation raised $23M on March 12, 2004

Investors: HealthCare Ventures LLC

FAQ